* Heartbeam Inc BEAT.OQ BEAT.O is expected to show no
change
in quarterly revenue when it reports results on May 11.
*
* Refinitiv's mean analyst estimate for Heartbeam Inc is
for a
loss of 31 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 21.1%
in the last three months.
* Wall Street's median 12-month price target for Heartbeam
Inc is
$9, above its last closing price of $2.25.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.48 -0.37 -0.45 Missed -22.7
Sep. 30 2022 -0.33 -0.32 -0.44 Missed -35.4
Jun. 30 2022 -0.27 -0.43 Missed -59.3
Mar. 31 2022 -0.19 -0.19 -0.27 Missed -42.1
Dec. -0.11
31 2021
This summary was machine generated May 10 at 02:01 GMT. All
figures in US dollars unless otherwise stated